After studying one company with a guide, can you investigate another yourself? Costco's memberships, renewals, and warehouses form a familiar explanation. Carrying that conclusion into Target could overlook product categories, fulfillment, and inventory. A method can travel; its conclusion needs fresh evidence.
Your deliverable is a report someone else can check. Save a judgment from the first package, examine a second cutoff, then locate one additional original disclosure yourself. Continuing research, finding insufficient evidence, or declining to participate are acceptable conclusions. The later stock price cannot grade the report by itself.
Separate the assignment from the answer
Complete three tasks: write an initial report with evidence that could challenge it; preserve that version and explain what new information changes; independently obtain a field and explain its relevance. The first two transfer a method to supplied materials. The third tests an additional skill: finding the evidence yourself.
Open the C1-B package, whose supporting instructions and examples are currently in Chinese, with original English filings linked. Begin only with T1's materials, numerical tables, and task. T1 is December 31, 2024; T2 is April 30, 2025. Separate files guide reading order; no enforced website unlock is claimed.
The authors know the subsequent history. This is a historical teaching reconstruction. If you know the outcome or have already read T2, label your work retrospective reconstruction. Do not let AI read the entire directory first and then describe its initial report as an independent judgment on unseen material.
Establish the issuer, document, and availability date
C1-B concerns Target Corporation, ticker TGT, CIK 0000027419, distinct from Costco's C1-A. T1 includes the FY2023 annual report, Q3 FY2024 quarterly report, relevant 2024 proxy sections, and the November 20, 2024 company release. All were public before T1. The package preserves links and locators.
The FY2023 annual report ends February 3, 2024; its SEC filing date is March 13, 2024. Fiscal label, period-end, and publication date are different facts.[1] The Q3 report ends November 2 and was filed November 27, with Accepted shown as 14:16:36 on the index. The earlier release appeared November 20. These are two disclosures about one quarter, not two independent operating outcomes.[2]
C1-R elsewhere identifies retrospective reading use. It does not mean every document bearing that label was unavailable at both cutoffs. Target's FY2024 10-K can enter T2, but not T1. Costco's report for the year ended August 31, 2025 cannot enter either. Decide eligibility document by document from public availability.
These fact cards reconstruct currently accessible historical originals; they are not contemporaneous downloaded snapshots or a complete archive of everything the market knew. They cover the assignment's limited question, not an independent audit of the company's reports. Current website navigation can also reveal later information: restrict evidence to the specified historical documents and passages.
Save a first report before reading the demonstration
Complete the T1 assignment, with Chinese instructions: one research question, a business-and-cost map, at least three financial observations, contrary evidence, conditional valuation, missing information, and review triggers. Attach original fields and sources, identify dates, and mark judgments as judgments. Save the version before continuing.
A workable question is: “Do improving customer traffic and digital business also support better profitability and cash generation?” It is more answerable than “Should I buy Target?” It also avoids forcing incomplete price or capital-requirement evidence into a trading conclusion.
Map purchases through stores and digital ordering to procurement, fulfillment, labor, leases, and capital investment. Stores also fulfill digital orders; the two channels are not economically unrelated businesses. A membership program alone does not justify importing Costco's profit structure.
Governance has evidence too. The 2024 proxy describes long-term incentive instruments and relative peer metrics; the compensation advisory vote does not directly compel board action.[3] Ask how sales, EPS, and capital efficiency interact. A compensation percentage cannot establish management's actual motives.
Let a favorable fact meet an unfavorable one
Use millions of US dollars, except per-share amounts and percentages. Q3 total revenue increases from 25,398 to 25,668, approximately 1.063% using the rounded table inputs. Operating income falls from 1,317 to 1,168. Dividing each by matching total revenue gives margins of approximately 5.185% and 4.550%. Revenue growth has not independently established a profitability recovery.
First-nine-month net earnings rise from 2,756 to 2,988, approximately 8.418%, while operating cash falls from 5,332 to 4,078, approximately 23.518%. That difference motivates investigation, not an allegation of fabricated earnings. Inspect inventory, payables, and tax and incentive-payment timing. Management's explanation remains an explanation to check, not independently established complete causation.
Inventory of 15,165 is approximately 27.587% above fiscal-start 11,886, but only 2.946% above 14,731 at the comparable prior seasonal point. Both comparisons answer useful, different questions. Holiday stocking matters. Choosing only the larger change cannot establish unsalable stock; choosing only the smaller cannot remove the concern.
Another cash measure moves favorably: operating cash minus property-and-equipment expenditure is 4,078 − 1,968 = 2,110, against 5,332 − 3,952 = 1,380. Lower spending raises this defined residual. Not every cash measure worsened, but reduced investment does not automatically create permanent value.
This residual does not handle complete capital needs, financing, and shareholder cash flows, so it is not ready-made DCF free cash flow. Keep cash of 3,433 beside current and noncurrent debt and leases; a balance does not resolve the maturity schedule. Compare your saved first version with the separate T1 example, currently in Chinese, identifying differences rather than replacing your record.
Valuation needs explicit inputs and honest blanks
Verified historical prices at the two cutoffs have not been obtained. Do not infer how cheap Target actually was, backfill today's price, or substitute an average repurchase price for an executable historical quote.
For a separate sensitivity exercise, assume a $120 price, normalized EPS of $7, $8.60, or $10, and corresponding P/E multiples of 12, 15, or 18. These are teaching assumptions, not validated normalized earnings or real Target price targets.
The resulting values are $84, $129, and $180: gaps of −30%, +7.5%, and +50% relative to assumed $120. No realization time, dividends, taxes, costs, or probabilities are included. These are valuation gaps, not expected investment returns.
The middle gap is only 7.5%. At a fixed 15 multiple, $120 corresponds to $8 EPS, approximately 6.98% below the assumed $8.60. That single downward change removes the apparent gap. The calculation identifies an assumption needing evidence; it does not predict actual EPS.
$8.60 also happens to be the midpoint of the company's then-current $8.30–$8.90 full-year guidance. A midpoint is not a mathematical expectation, and one year's guidance is not long-run normalized earnings. Sustainable margins, reinvestment, share count, and capital structure still need explanations.
A complete conclusion can therefore say: partial operating recovery warrants investigation, but broad improvement in profitability and cash is unconfirmed; price evidence and key assumptions are missing, so continue research without a real purchase recommendation. Completeness comes from reasons and next steps, not a compulsory buy or sell label.
Update both the facts and the measuring stick
After freezing your first report, open T2 inputs, with Chinese instructions. Write your change record before reading the Chinese update example. T2 adds the March 4, 2025 release and FY2024 SEC 10-K filed March 12, covering the year ended February 1, 2025. Both precede April 30.[4]
Before pasting numbers into the old table, check period length, line labels, revenue scope, and reclassification of comparatives. FY2024 has 52 weeks against FY2023's 53. The new Net sales line represents the former Total revenue, not only the old merchandise Sales line. Prior-year cost of sales and SG&A are reclassified by equal, opposite $92 million amounts without changing operating income. Preserve T1's original presentation and add a dated mapping at T2.
Organize the update into facts, assumptions, valuation, and action. New annual results can support one part while weakening another. Meeting guidance does not establish normalized earnings, a sound valuation, or research skill. Missing actual prices remain missing even after more documents arrive.
Make review triggers traceable. If the next original disclosure shows better comparable sales without supporting margins or cash, revisit “broad recovery.” If a change is presentation alone, bridge definitions before claiming economic change. Include evidence you would least like to see, so the report remains capable of changing your mind.
Obtain another original yourself
Recalculating supplied cards is not independent source acquisition. The authors' source demonstration, currently in Chinese locates Target's August 21, 2024 Q2 release, checks issuer, title, period, and units, then extracts three-month revenue of 25,452 and operating income of 1,635. Their ratio gives approximately 6.424% operating margin.[5]
The release's table is marked unaudited. It is not a 10-K, and its exact publication time was not established. Do not invent an SEC Accepted timestamp. Opening a URL alone does not prove correct extraction.
Your independent task needs another relevant original disclosure not excerpted in the closed package or demonstration. For use in T1, publication must be no later than December 31, 2024; for T2, no later than April 30, 2025. Later evidence starts a separately dated observation instead of rewriting either frozen report.
Save your actual query or navigation path, title, CIK, reporting period, public availability, field location, and raw value. Recalculate a derived measure and explain which judgment it changes—or why it remains insufficient. If access fails, preserve the failure and try another official route. The supplied report can be complete while independent acquisition remains incomplete. A secondary summary cannot become an original merely by changing its label.
Test the boundary with a changed price
Explain why rising quarterly revenue and falling margin establish neither successful broad recovery nor permanent business failure. Then decide whether a newly reclassified T2 comparison table may overwrite T1 for neatness. Write reasons first.
The first observation covers limited periods and dimensions; mechanism, seasonality, and persistence remain to investigate. Overwriting T1 would erase what was available then. Retain its version and add the new mapping and publication date separately.
For transfer, keep the middle valuation $8.60 × 15 = $129, but change only the teaching price from $120 to $160. Recalculate the gap and decide whether disclosure facts or actual market conclusions change.
$129 / $160 − 1 = −19.375%. The assumed-price valuation gap changes; original financial facts do not. $160 is also not a verified historical quote. A real action still needs contemporaneous price evidence, complete assumptions, and funding constraints; this exercise cannot establish a real sell decision.
Deliver the research without approving implementation
Keep T03's question and mechanism, T02's facts, inferences, contrary evidence and sources, the frozen T04 first report, the T2 update and change log, and the additional original you actually obtained. A reviewer should choose a key conclusion, find its source, recompute it, and see unresolved issues.
Assess timing, consistent definitions, effective contrary evidence, fact–assumption separation, and version preservation. Neither a buy label nor later price direction substitutes for those checks. Demonstrations support the supplied task; they do not sign off the reader's independent research, RES. Retain incomplete acquisition or reasoning where it belongs.
G72/G73 establish household context. Full RISK and account/implementation RUN remain separate. A complete report can coexist with zero real funding, without any application being required to establish the learning task.
Freeze available evidence, let business, finance, and conditional valuation challenge each other, and leave missing inputs blank. Then explain what the second cutoff changes and obtain another original. Traceable judgments support future updates; hindsight cannot complete research, funding, and operation on your behalf.
References
- Target FY2023 10-K SEC index, filed March 13, 2024; original report, business and financial statements.
- Target Q3 FY2024 10-Q and SEC index, filed November 27, 2024. The earlier November 20 release is linked in T1's source table.
- Target 2024 DEF 14A, filed April 29, 2024, printed pages 46–48 and 72; identity index.
- Target FY2024 10-K SEC index, filed March 12, 2025; original report. T2 only; its March 4 release is linked in the T2 source table.
- Target Q2 FY2024 original earnings release, August 21, 2024, Consolidated Statements of Operations, three-month column.
Sources checked October 30, 2026. Historical disclosures and teaching valuation assumptions remain separate. AI-assisted draft; independent AI full-text and bilingual review is complete. Human financial review and target-reader testing have not been conducted and are not scheduled for this production round.